Apr 26, 2011

Wockhardt Receives FDA Approval to Sell Generic Aricept

Lower prices for generic Aricept should allow more Alzheimer's patients to receive the drug...
By Bob DeMarco
Alzheimer's Reading Room

What is
Alzheimer's disease?
Pharmaceutical and biotechnology company Wockhardt has received tentative approval from the United States Food and Drug Administration (FDA) to market and sell 5mg and 10mg tablets of Donepezil HCl, which is used for treatment of Alzheimer’s disease and dementia.

Donepezil is the generic name for the brand Aricept®, marketed in the United States by Eisai in partnership with Pfizer. Wockhardt will be launching the product in the US market on May 28, 2011. According to IMS Health, the total market for this product in the US is about $2.5 billion.

Subscribe to the Alzheimer's Reading Room
Enter Your Email Address

Read More on the Alzheimer's Reading Room

Bob DeMarco is the Founder of the Alzheimer's Reading Room and an Alzheimer's caregiver. The blog contains more than 2,560 articles with more than 412,100 links on the Internet. Bob resides in Delray Beach, FL.

The Alzheimer’s Action Plan: The Experts’ Guide to the Best Diag­no­sis and Treat­ment for Mem­ory Prob­lems
The 36-Hour Day A Family Guide to Caring for People with Alzheimer Disease

Original content Bob DeMarco, the Alzheimer's Reading Room